Abstract: Rhegmatogenous retinal detachment (RRD) is a vision-threatening condition that requires early and accurate detection for effective treatment. In this study, we utilized Ultra-Widefield ...
Abstract: Accurate automatic segmentation of blood vessels in ophthalmic images is crucial for the early diagnosis of many diseases. These images are typically high-resolution and contain intricate ...
Move over Godzilla and King Kong, the United States and Japan aren’t the only countries capable of crafting massive monster epics! Norway is jumping into the kaiju arena with its own spin on a ...
What Is Eylea HD, and Why Does It Matter? Eylea HD (aflibercept) is an injectable medicine used to treat certain eye conditions that can lead to vision loss. It works by blocking a protein called VEGF ...
Please provide your email address to receive an email when new articles are posted on . The decision is supported by positive visual acuity gains found in the phase 3 QUASAR trial. This is the fourth ...
7 Ways the Big Beautiful Bill Cuts Taxes for the Rich Overall, the Big Beautiful Bill will harm poor Americans and raise the incomes of rich Americans—driving gains for the rich through cuts to ...
Eylea HD 8 mg is approved for macular edema post-retinal vein occlusion, with dosing every 8 weeks after initial monthly treatment. The QUASAR trial showed Eylea HD's non-inferior visual acuity gains ...
TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD ® (aflibercept) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback